ACADIA Pharmaceuticals Inc. earnings per share and revenue

ACAD earnings per share for the last quarter are 0.86 USD whereas the estimation was 0.22 USD which accounts for 298.68% surprise. Company revenue for the same period amounts to 259.60 M USD despite the estimated figure of 255.61 M USD. Estimated earnings per share for the next quarter are -0.02 USD, and revenue is expected to reach 239.55 M USD. Also watch annual changes over time to get a bigger picture of ACAD earnings per share and revenue dynamics.